SUMMARYCryotolerant eukaryotic microalgae were isolated from meltwater streams on Ardley Island and King George Island in Antarctica, and their morphological, molecular, and physiological characteristics were investigated. Owing to their simple morphology, distinctive characters were not observed with neither light microscopy nor transmission electron microscopy. However, molecular phylogenetic inferences drawn from the concatenated small subunit rRNA and internal transcribed spacer sequence data indicated that these microalgal strains belonged to the genus Micractinium. All the Micractinium strains showed cryotolerant properties, while their optimum growth temperature was around 20°C. Similar to other cryotolerant organisms, these Antarctic microalgae also contained a higher ratio of polyunsaturated fatty acids to saturated fatty acids. In this study, new Antarctic Micractinium spp. were discovered and added to the culture collection. These cryotolerant strains may serve as a promising source of nutritionally important linoleic (C18:2 ω6) and α-linolenic (C18:3 ω3) acids.
A cold-tolerant unicellular green alga was isolated from a meltwater stream on King George Island, Antarctica. Morphological, molecular, and biochemical analyses revealed that the isolate belonged to the species Chlorella vulgaris. We tentatively named this algal strain C.vulgaris KNUA007 and investigated its growth and lipid composition. We found that the strain was able to thrive in a wide range of temperatures, from 5 to 30 °C; however, it did not survive at 35 °C. Ultimate analysis confirmed high gross calorific values only at low temperatures (10 °C), with comparable values to land plants for biomass fuel. Gas chromatography/mass spectrometry analysis revealed that the isolate was rich in nutritionally important polyunsaturated fatty acids (PUFAs). The major fatty acid components were hexadecatrienoic acid (C16:3 ω3, 17.31%), linoleic acid (C18:2 ω6, 8.52%), and α-linolenic acid (C18:3 ω3, 43.35%) at 10 °C. The microalga was tolerant to low temperatures, making it an attractive candidate for the production of biochemicals under cold weather conditions. Therefore, this Antarctic microalga may have potential as an alternative to fish and/or plant oils as a source of omega-3 PUFA. The temperature tolerance and composition of C.vulgaris KNUA007 also make the isolate desirable for commercial applications in the pharmaceutical industry.
Water scarcity and emerging demands for renewable energy have increased concerns about energy security and advanced wastewater treatment, and microalgae have emerged as promising candidates to solve these problems. This study assesses the feasibility of microalgal wastewater treatment, and the utilization of the resulting microalgal biomass, as a renewable energy source. We cultured four selected microalgal species in filtered wastewater collected from the municipal treatment facility in Daegu, Republic of Korea. We measured nutrient consumption, growth rate, and physicochemical properties during cultivation, then analyzed the biomass for biochemical composition, ultimate analysis, proximate analysis, and biodiesel and lubricant properties, to estimate its potential applications. Desmodesmus sp. KNUA024 emerged as the most promising strain, removing 99.10% of ammonia nitrogen, 91.31% of total nitrogen, and 95.67% of total phosphate. Its biomass had a calorific value of 19.5 MJ kg−1, similar to terrestrial plants. α-linolenic acid was the most abundant polyunsaturated fatty acid (PUFA; 54.83%). Due to its PUFA content, Desmodesmus sp. KNUA024 also had a high iodine value, indicating its potential for use as a bio-lubricant. Therefore, Desmodesmus sp. KNUA024 shows promise for wastewater treatment, energy, and industrial applications.
Metagenome studies have provided us with insights into the complex interactions of microorganisms with their environments and hosts. Few studies have focused on microalgae-associated metagenomes, and no study has addressed aquatic microalgae and their bacterial communities in open pond raceways (OPRs). This study explored the possibility of using microalgal biomasses from OPRs for biodiesel and biofertilizer production. The fatty acid profiles of the biomasses and the physical and chemical properties of derived fuels were evaluated. In addition, the phenotype-based environmental adaptation ability of soybean plants was assessed. The growth rate, biomass, and lipid productivity of microalgae were also examined during mass cultivation from April to November 2017. Metagenomics analysis using MiSeq identified ∼127 eukaryotic phylotypes following mass cultivation with (OPR 1) or without (OPR 3) a semitransparent film. Of these, ∼80 phylotypes were found in both OPRs, while 23 and 24 phylotypes were identified in OPRs 1 and 3, respectively. The phylotypes belonged to various genera, such as Desmodesmus, Pseudopediastrum, Tetradesmus, and Chlorella, of which, the dominant microalgal species was Desmodesmus sp. On average, OPRs 1 and 3 produced ∼8.6 and 9.9 g m−2 d−1 (0.307 and 0.309 DW L−1) of total biomass, respectively, of which 14.0 and 13.3 wt% respectively, was lipid content. Fatty acid profiling revealed that total saturated fatty acids (mainly C16:0) of biodiesel obtained from the microalgal biomasses in OPRs 1 and 3 were 34.93% and 32.85%, respectively; total monounsaturated fatty acids (C16:1 and C18:1) were 32.40% and 31.64%, respectively; and polyunsaturated fatty acids (including C18:3) were 32.68% and 35.50%, respectively. Fuel properties determined by empirical equations were within the limits of biodiesel standards ASTM D6751 and EN 14214. Culture solutions with or without microalgal biomasses enhanced the environmental adaptation ability of soybean plants, increasing their seed production. Therefore, microalgal biomass produced through mass cultivation is excellent feedstock for producing high-quality biodiesel and biofertilizer.
Ototoxicity, or adverse pharmacological effects on the inner ear or auditory nerve, is a common side effect of cisplatin, a platinum-based drug widely used in anticancer chemotherapy. Although the incidence of ototoxicity is high among patients that receive cisplatin therapy, there is currently no effective treatment for it. The generation of excessive reactive oxygen species (ROS) is considered to be the major cause of cisplatin-induced ototoxicity. C-phycocyanin (C-PC), a blue phycobiliprotein found in cyanobacteria and red algae, has antioxidant and anticancer activities in different experimental models in vitro and in vivo. Thus, we tested the ability of C-PC from Limnothrix sp. KNUA002 to protect auditory cells from cisplatin-induced ototoxicity in vitro. Pretreatment with C-PC from Limnothrix sp. KNUA002 inhibited apoptosis and protected mitochondrial function by preventing ROS accumulation in cisplatin-treated House Ear Institute-Organ of Corti 1 (HEI-OC1) cells, a mouse auditory cell line. Cisplatin increased the expression of Bax and reduced the expression of Bcl-2, which activate and inhibit, respectively, the mitochondrial apoptotic pathway in response to oxidative stress. Pretreatment with C-PC prior to cisplatin treatment caused the Bax and Bcl-2 levels to stay close to the levels in untreated control cells. Our results suggest that C-PC from Limnothrix sp. KNUA002 protects cells against cisplatin-induced cytotoxicity by inhibiting the mitochondrial apoptotic pathway.
Recently, photosynthetic microalgae have gained particular interest as a new source for industrially important biomolecules because they are able to convert carbon dioxide (CO 2) to various types of products such as carbohydrates, lipids, and proteins with minimal growth requirements [6, 29]. In particular, microalgae are now considered as one of the most attractive candidates for biofuel and polyunsaturated fatty acid (PUFA) production due to their higher photosynthetic efficiency and oil yield compared to terrestrial crops [16, 20, 37]. In this study, a Korean indigenous microalga, Chlorella vulgaris KNUA027 was isolated and identified, and its potential as biofuel and PUFA feedstock was investigated. Algal samples growing around the root of Panax ginseng seedlings on Petri dish at Sangju Campus, Kyungpook National University (36 o 22'N, 128 o 08'E) were collected in February 2013. Samples were then inoculated into 100 ml BG-11 medium [30] (Table 1) with meropenem (Yuhan Pharmaceuticals, Korea) at a concentration of 100 µg/ml. The flasks were incubated at 25℃ with shaking at 160 rpm under cool fluorescent light (approximately 70 µmole m-2 s-1) until algal growth was apparent. Well-grown algal cultures (1.5 ml) were centrifuged at 3,000 × g for 15 min (Centrifuge 5424, Eppendorf, Germany) and resulting pellets were streaked onto BG-11 agar supplemented with meropenem (20 µg/ ml). Plates were then incubated in a light:dark cycle (16:8 h) at 25℃ and a single colony was aseptically A unicellular green alga, Chlorella vulgaris KNUA027, was isolated from the roots of Panax ginseng seedlings and its biotechnological potential was investigated. The results of GC/MS analysis showed that C. vulgaris KNUA027 was rich in nutritionally important polyunsaturated fatty acids (PUFAs) such as alphalinolenic acid (C 18:3 ω3, 45.8%, 50.8 mg/g) and hexadecatrienoic acid (C 16:3 ω3, 11.8%, 13.1 mg/g). Therefore, this Korean indigenous microalga may have potential as a source of omega-3 PUFAs. It was also found that the saturated palmitic acid (C 16:0 , 37.1%, 41.2 mg/g), which is suitable for biodiesel production, was one of the major fatty acids produced by strain KNUA027. The proximate analysis showed that the volatile matter content was 88.5%, and the ultimate analysis indicated that the higher heating value was 19.8 MJ/kg. Therefore, the results from this research with C. vulgaris KNUA027 may provide the basis for the production of microalgae-based biofuels and biomass feedstock.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.